...
首页> 外文期刊>World Journal of Gastroenterology >Mutations in surface and polymerase gene of chronic hepatitis B patients with coexisting HBsAg and anti-HBs.
【24h】

Mutations in surface and polymerase gene of chronic hepatitis B patients with coexisting HBsAg and anti-HBs.

机译:慢性乙型肝炎患者合并HBsAg和抗HBs的表面和聚合酶基因突变。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To investigate the clinical significance and presence of mutations in the surface (S) and overlapping polymerase gene of hepatitis B patients with coexisting HBsAg and anti-HBs. METHODS: Twenty-three patients with chronic hepatitis B were studied. Of the 23 patients, 11 were both positive for hepatitis B virus (HBV) surface antigen (HBsAg) and antibody to HBV surface antigen (anti-HBs), 12 were negative for anti-HBs while positive for HBsAg. DNA was extracted from 200 muL serum of the patients. Nucleotide of the surface and overlapping polymerase gene from HBV-infected patients was amplified by PCR, and the PCR products were sequenced. RESULTS: Forty-one mutations were found within the surface gene protein of HBV in 15 patients (10 with coexisting HBsAg and anti-HBs). Six (14.6%) out of 41 mutations were located at "alpha " determinant region in 5 patients (4 positive for HBsAg and anti-HBs). Eleven mutations (26.8%) occurred in the downstream or upstream of "alpha " determinant region. Lamivudine(LMV)-selected mutations were found in three patients who developed anti-HBs, which occurred in amino acid positions (196, 198, 199) of the surface protein and in YMDD motif (M204I/V) of the polymerase protein simultaneously. Presence of these mutations did not relate to changes in ALT and HBV DNA levels. CONCLUSION: Besides mutations in the "alpha " deter-minant region, mutations at downstream or upstream of the "alpha " determinant region may contribute to the development of anti-HBs. These mutations do not block the replicating competency of HBV in the presence of high titer of anti-HBs.
机译:目的:探讨并存HBsAg和抗HBs的乙型肝炎患者表面和重叠聚合酶基因突变的临床意义和存在性。方法:对23例慢性乙型肝炎患者进行了研究。在这23例患者中,有11例均为乙型肝炎病毒(HBV)表面抗原(HBsAg)和抗HBV表面抗原(抗HBs)阳性,12例抗HBs阴性,而HBsAg阳性。从200μL患者的血清中提取DNA。通过PCR扩增HBV感染患者的表面和重叠聚合酶基因的核苷酸,并对PCR产物进行测序。结果:15例患者的HBV表面基因蛋白内发现了41个突变(其中10例同时存在HBsAg和抗HBs)。 41例突变中有6例(占14.6%)位于5例患者的“ alpha”决定簇区域(4例HBsAg和抗HBs阳性)。在“ alpha”决定簇区域的下游或上游发生了11个突变(26.8%)。在三名产生抗HBs的患者中发现了拉米夫定(LMV)选择的突变,这些突变同时发生在表面蛋白的氨基酸位置(196、198、199)和聚合酶蛋白的YMDD基序(M204I / V)中。这些突变的存在与ALT和HBV DNA水平的变化无关。结论:除“α”决定簇区域的突变外,“α”决定簇区域下游或上游的突变可能有助于抗HBs的发生。在高滴度的抗HBs的存在下,这些突变不会阻止HBV的复制能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号